Shaily Garg

558 total citations
9 papers, 415 citations indexed

About

Shaily Garg is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Shaily Garg has authored 9 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Epidemiology. Recurrent topics in Shaily Garg's work include Viral gastroenteritis research and epidemiology (3 papers), Respiratory viral infections research (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Shaily Garg is often cited by papers focused on Viral gastroenteritis research and epidemiology (3 papers), Respiratory viral infections research (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Shaily Garg collaborates with scholars based in United States and Austria. Shaily Garg's co-authors include Sean N. Tucker, David Liebowitz, Keith Gottlieb, Jonathan D. Lindbloom, Paul Sims, Marcela F. Pasetti, Leesun Kim, Nikita Kolhatkar, Jason Asher and Kenneth H. Kim and has published in prestigious journals such as Hepatology, The Journal of Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Shaily Garg

9 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shaily Garg United States	7	197	111	81	79	73	9	415
Guilhem Cros France	10	145 0.7×	82 0.7×	49 0.6×	60 0.8×	103 1.4×	16	392
Kwang Nam Kim South Korea	10	120 0.6×	124 1.1×	35 0.4×	50 0.6×	52 0.7×	42	365
Rudolf Stefan Ross Germany	10	160 0.8×	355 3.2×	209 2.6×	56 0.7×	85 1.2×	14	723
Lenora M. Noroski United States	14	135 0.7×	158 1.4×	29 0.4×	52 0.7×	124 1.7×	26	549
Masakazu Umemoto Japan	11	93 0.5×	62 0.6×	74 0.9×	50 0.6×	17 0.2×	28	291
Maria Söderlund Finland	12	395 2.0×	145 1.3×	50 0.6×	22 0.3×	70 1.0×	15	612
J. A. López Spain	9	85 0.4×	144 1.3×	92 1.1×	76 1.0×	13 0.2×	20	354
Stavroula Masouridi‐Levrat Switzerland	14	170 0.9×	309 2.8×	170 2.1×	22 0.3×	41 0.6×	60	603
Fatma Berri France	11	264 1.3×	213 1.9×	64 0.8×	53 0.7×	25 0.3×	19	580
Yukio Itoh Japan	10	148 0.8×	268 2.4×	19 0.2×	55 0.7×	53 0.7×	20	509

Countries citing papers authored by Shaily Garg

Since Specialization

Citations

This map shows the geographic impact of Shaily Garg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaily Garg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaily Garg more than expected).

Fields of papers citing papers by Shaily Garg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaily Garg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaily Garg. The network helps show where Shaily Garg may publish in the future.

Co-authorship network of co-authors of Shaily Garg

This figure shows the co-authorship network connecting the top 25 collaborators of Shaily Garg. A scholar is included among the top collaborators of Shaily Garg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaily Garg. Shaily Garg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Johnson, Susan, et al.. (2021). 589. Oral Tablet Vaccination Induces Heightened Cross-Reactive CD8 T Cell Responses to SARS-COV-2 in Humans. Open Forum Infectious Diseases. 8(Supplement_1). S397–S397. 6 indexed citations

Liebowitz, David, Keith Gottlieb, Nikita Kolhatkar, et al.. (2020). Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study. The Lancet Infectious Diseases. 20(4). 435–444. 87 indexed citations

Mateo, Roberto, et al.. (2019). 78. Oral Norovirus Vaccination in Humans Induces Plasmablast B-Cell Expansion and Follicular T-Cell Activation Comparable to Natural Infection. Open Forum Infectious Diseases. 6(Supplement_2). S2–S2. 1 indexed citations

Mateo, Roberto, Lisa C. Lindesmith, Shaily Garg, et al.. (2019). Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development. The Journal of Infectious Diseases. 221(6). 919–926. 8 indexed citations

Kim, Leesun, David Liebowitz, Marcela F. Pasetti, et al.. (2018). Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial. JCI Insight. 3(13). 100 indexed citations

Liebowitz, David, et al.. (2015). High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial. The Lancet Infectious Diseases. 15(9). 1041–1048. 66 indexed citations

Sola, Martha C., Sandra E. Juul, Yuesheng Meng, et al.. (1999). Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development. Early Human Development. 53(3). 239–250. 38 indexed citations

Peck‐Radosavljevic, Markus, Martina Wichlas, Johann Pidlich, et al.. (1998). Blunted Thrombopoietin Response to Interferon Alfa-Induced Thrombocytopenia During Treatment for Hepatitis C. Hepatology. 28(5). 1424–1429. 78 indexed citations

Wong, Wai Lee, Shaily Garg, Teresa K. Woodruff, et al.. (1993). Monoclonal antibody based ELISAs for measurement of activins in biological fluids. Journal of Immunological Methods. 165(1). 1–10. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact